Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,783,078
+$36,495 QoQ
Shares Held
4,924
-0.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,348
of 3,149 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MAIRS & POWER INC holds $516,794,572 across 8 Drug Manufacturers - General names. AMGN ranks #5 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
322,129 | $386,371,218 | |
| 2 | JNJ |
Johnson & Johnson
|
423,010 | $107,431,849 | |
| 3 | ABBV |
AbbVie Inc.
|
44,702 | $11,248,811 | |
| 4 | MRK |
Merck & Co., Inc.
|
51,519 | $6,620,191 | |
| 5 | AMGN |
Amgen Inc
This page
|
4,924 | $1,783,078 | |
| 6 | PFE |
Pfizer Inc
|
67,679 | $1,629,710 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
24,684 | $1,422,292 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,275 | $287,423 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,783,078 | 4,924 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,746,583 | 4,964 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,808,060 | 5,524 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,599,227 | 5,667 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,630,027 | 5,838 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,545,599 | 4,961 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,461,408 | 5,607 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,916,505 | 5,948 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,859,077 | 5,950 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,071,271 | 7,285 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,150,069 | 7,465 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,008,981 | 7,475 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,695,566 | 7,637 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,116,279 | 8,754 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,337,233 | 8,899 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,013,949 | 8,935 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,187,996 | 8,993 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,101,899 | 8,692 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,927,317 | 8,567 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,835,169 | 8,630 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,042,625 | 8,380 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,103,688 | 8,455 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,952,020 | 8,490 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,148,922 | 8,455 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,976,506 | 8,380 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,698,877 | 8,380 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||